×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Actinogen's Capital Raise to Advance Alzheimer's Trial - TipRanks.com
Tipranks
Actinogen Medical Limited (AU:ACW) has released an update. Actinogen Medical Limited is embarking on a $3.9 million capital raise through a non-renounceable...
17 hours ago
Actinogen finishes enrolling patients in depression therapy trial
Clinical Trials Arena
Actinogen Medical has finished enrolling subjects in a Phase IIa trial of Xanamem for treating cognitive impairment associated with MDD.
3 weeks ago
Investors in Actinogen Medical (ASX:ACW) have unfortunately lost 53% over the last year
Yahoo Finance
Investors in Actinogen Medical (ASX:ACW) have unfortunately lost 53% over the last year ... In this article: ATGGF. Actinogen Medical Limited (ASX...
2 months ago
Actinogen XanaCIDD Phase 2a trial in patients with depression and cognitive impairment: enrolment accelerating and ...
PR Newswire
28, 2023 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that enrolment in the XanaCIDD Phase 2a proof-of-concept trial in 160...
5 months ago
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update
BioSpace
Actinogen Medical Limited (ASX: ACW) is pleased to announce optimization of the XanaMIA Phase 2b trial in patients with mild-to-moderate...
7 months ago
Actinogen treats first subject in Alzheimer's disease therapy trial
Clinical Trials Arena
Actinogen Medical has treated the first subject in the XanaMIA Phase IIb clinical trial of Xanamem in Alzheimer's disease (AD) patients.
1 month ago
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?
Simply Wall Street
We can readily understand why investors are attracted to unprofitable companies. For example, although...
2 weeks ago
Actinogen Medical Explores Breakthrough in Cognitive Treatment - TipRanks.com
Tipranks
Actinogen Medical Limited (AU:ACW) has released an update. Actinogen Medical is gearing up to present a webinar featuring renowned experts...
2 days ago
Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial
PR Newswire
PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces the full enrolment of 167 participants in the Company's XanaCIDD phase 2a...
3 weeks ago
Australia's Actinogen plunges on discounted capital raising
XM
... ** Shares of Australia's biotechnology company Actinogen Medical Ltd ACW.AX fall as much as 23.7% to A$0.029, set for biggest daily...
2 weeks ago